Merck KGaA (MKGAF)
OTCMKTS
· Delayed Price · Currency is USD
139.20
-5.95 (-4.10%)
Feb 21, 2025, 3:53 PM EST
Merck KGaA Revenue
Merck KGaA had revenue of 5.27B EUR in the quarter ending September 30, 2024, with 1.80% growth. This brings the company's revenue in the last twelve months to 20.96B, down -2.17% year-over-year. In the year 2023, Merck KGaA had annual revenue of 20.99B, down -5.57%.
Revenue (ttm)
20.96B EUR
Revenue Growth
-2.17%
P/S Ratio
n/a
Revenue / Employee
333.23K EUR
Employees
62,908
Market Cap
61.57B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
Dec 31, 2019 | 16.15B | 1.32B | 8.87% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
SANUWAVE Health | 29.30M |
Merck KGaA News
- 6 days ago - Merck KGaA to replace two executives with company veterans - Reuters
- 12 days ago - Germany's Merck In Talks To Buy Cancer Drug Maker SpringWorks Therapeutics - Benzinga
- 13 days ago - Crude Oil Rises Sharply; Manhattan Associates Shares Slide - Benzinga
- 13 days ago - Rockwell Automation Posts Upbeat Earnings, Joins Insperity, BP, Alibaba And Other Big Stocks Moving Higher On Monday - Benzinga
- 13 days ago - SpringWorks Therapeutics jumps on report of Merck KGaA takeover talks - Seeking Alpha
- 13 days ago - Exclusive: Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say - Reuters
- 4 weeks ago - Merck KGaA says high asset prices call for prudent M&A approach - Reuters
- 4 weeks ago - MilliporeSigma Partners with Opentrons Labworks, Inc., Supporting Lab of the Future - Financial Post